Home / Intelligence / Scientific Publications / U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
Prader-Willi syndrome (PWS) is a complex developmental genetic disorder associated with hypotonia, poor feeding in neonates, onset of hyperphagia in early childhood, and shorter overall life expectancy. Prior epidemiology studies of PWS have examined smaller populations, with limited research in a US population. The aim of this study was to provide a contemporary estimate of PWS prevalence and annual all-cause mortality in the US using a large administrative medical claims dataset.
Authors
Shawn McCandless, Marissa Suh, David Yin, Michael Yeh, Shawn Czado, Sina Aghsaei, Justin Li, Kevin Francis, Nandini Hadker, Diane Stafford
Journal
Journal of the Endocrine Society; Volume 4; Issue Supplement_1; April-May 2020
Related Intelligence
Webinars
Picking Winners: Portfolio Management for a New Era
May 30, 2024 | 1:00 – 1:45 PM ET
Two additional sessions will be offered: June 4, 2024 | 16:00-16:45 (UTC+8:00) – Asia/ShanghaiJune 4, 2024 | 15:00-15:45 CET – Europe/Berlin Did you know 62% of products launched between September 2019 and December 2021 underperformed expectations in the first year of launch? What is going wrong, and how can we get it right? Join Trinity Life […]
Sign Up Now
Blog
Rise with the waves: France – Accelerating Pricing and Market Access: Two Policies Shaping Pharma’s Future
Executive Summary The latest publication of new reimbursement regulations in the French Social Security Financing Act (PLFSS 2024), coupled with the recent approval of HEMGENIX® through the direct access scheme in France this past December, underline continued efforts in France to innovate its healthcare system. The 2024 PLFSS emphasizes: The direct access scheme is expected […]
Read More
Webinars
Unlock the Potential of Generative AI in Life Sciences Insights and Operations
May 2, 2024 | 1:00 – 1:45 PM ET
Two additional sessions will be offered: May 3, 2024 | 15:00-15:45 CET – Europe/Berlin May 8, 2024 | 16:00-16:45 (UTC+8:00) – Asia/Shanghai Generative AI (GenAI) has created an opportunity to re-think and significantly improve how we work. Although far from replacing humans, GenAI has the potential to make pharma professionals far more effective and valuable […]
Sign Up Now